Back to News
Market Impact: 0.25

1 Stock I'd Buy Before BP In 2026

NFLXNVDANDAQ
Company FundamentalsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)Renewable Energy TransitionESG & Climate PolicyManagement & GovernanceM&A & RestructuringCorporate Earnings
1 Stock I'd Buy Before BP In 2026

BP abandoned its 2020 transition plan to become an integrated low‑carbon energy company and is reallocating capital back to oil and gas, now expecting production growth into 2030, planning asset sales to cut debt and forecasting adjusted free cash flow growth of about 20% CAGR through 2027. By contrast, Exxon has focused on core advantaged assets, delivering $14.3 billion of structural cost savings since 2019, doubling unit earnings, and targeting $25 billion of additional earnings and $35 billion of incremental cash flow by 2030 (implying roughly 13% EPS CAGR), which it expects will fund continued dividend increases and buybacks — the author expresses greater confidence in Exxon over BP.

Analysis

Market structure: The immediate beneficiaries are low‑cost integrated producers (XOM, CVX) and oilfield service names with exposure to high‑margin upstream activity; losers are companies positioned as transition/renewables plays and BP (BP) which faces credibility and investor base erosion. BP’s pivot to growth in oil production versus its prior decline plan increases marginal supply expectations versus 2020 guidance, exerting mild downward pressure on Brent/WTI over the medium term if other majors follow suit. Cross‑asset: expect XOM credit spreads to compress 10–30bp on continued cash generation, BP spreads to remain wider until asset‑sale milestones; oil futures vol should tick up near catalysts, FX benefits to CAD/NOK if broader bullish oil view persists. Risk assessment: Tail risks include a >30% oil price collapse (WTI < $50) that would quickly reverse free‑cash‑flow assumptions, accelerated carbon regulation in the EU/UK raising SGA and divestiture costs, or failed BP asset sales that leave leverage elevated. Near term (days–weeks) risk is event volatility around earnings and asset‑sale updates; medium term (6–18 months) hinge on execution of capex reallocation and debt reduction; long term (3–5 years) depends on structural demand and carbon policy. Hidden dependencies: valuation sensitivity to oil price (each $10 move in WTI implies ~XOM/BP EPS swing materially altering the trade), and ESG fund flow reversals. Trade implications: Establish a 2–3% long position in XOM (6–18 month hold) and pair it with a 1–1.5% short in BP to capture relative execution/credibility spread; target 20–35% relative return if XOM meets its 13% EPS CAGR guidance and BP miscues. Use options to lever: buy 9–12 month XOM 10%‑OTM calls (size 0.5–1% portfolio) as asymmetric upside, and buy 6–9 month BP puts (0.5% size) as downside protection against failed deleveraging. Overweight integrated oils (XOM, CVX), underweight pure‑play renewables and transition contractors; add on XOM pullbacks of 5–10% or trim BP if net debt reduction <30% within 12 months. Contrarian angles: Consensus downplays that BP’s 20% FCF CAGR guide (through 2027) could re‑rate the stock if oil stays >$70 — the market may be over‑penalizing BP for strategy flip; conversely, investors may underprice Exxon's exposure to abrupt carbon policy shifts that could impose multibillion-dollar costs. Historical parallel: previous major strategic reversals (e.g., Shell/Total ROE shifts) show markets punish flip‑flopping but reward credible, sustained execution; unintended consequence — BP’s retreat from low‑carbon could trigger activist interest or a fire sale of assets at depressed multiples, amplifying short‑term downside.